Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has informed BSE that its Board of Directors will meet on Thursday, February 12, 2026, to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter and nine months ended December 31, 2025. In line with SEBI insider trading rules, the trading window for designated persons and their immediate relatives remains closed until 48 hours after the results are announced to the stock exchange. The intimation is filed under Regulation 29 of SEBI Listing Regulations. No financial figures or operational details have been disclosed in this notice — those will come after the board meeting on February 12.
This is a routine pre-results announcement and carries no direct impact on the stock. Investors should watch for the actual Q3FY26 unaudited numbers on or shortly after February 12, 2026, which will indicate the company's earnings performance for the December quarter. The closed trading window means insiders cannot trade until results are out, which is standard compliance.